Impact Factor
4.47
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
14.21
1,726 total citations
h5-index
71
h5 depth signal
Cited share
71.9%
92 of 128
Total citations
1,726
Citation footprint
Metric signal
15.97
External metric anchor
Self-citation
0.5%
9 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
158
United Kingdom
43
Canada
32
Australia
28
China
25
Citing Fields of Research
Cellular Membrane Transporters & Receptors
75
Neurosciences
50
Pharmacology & Toxicology
46
Immunology
36
Substance Abuse
31
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
2,353
Articles tracked across the journal lifetime
Indexed publication set
128
92 cited publications
Last 12 months
70
5.8 publications/month
Open access share
50.0%
35 OA publications in the last year
Leading citing country
United States
158 citing publications
Leading citing field
Cellular Membrane Transporters & Receptors
75 citing publications
Latest tracked publication
20 October 2026
10 recent records available
Coverage & Indexing History
v17n3,Sept. 1965-
v17n3,Sept. 1965-
Active Coverage
Active Coverage
Research Focus & Classification
Indexed Subjects
Neurodegenerative Disorders
Cellular Membrane Transporters & Receptors
Immunology
Cardiology
Diabetes
Neurosciences
Pharmacology & Toxicology
Issuing & Sponsoring Bodies
Contributor
American Society for Pharmacology and Experimental Therapeutics
Contributor
British Pharmacological Society
Contributor
Nordisk selskab för farmakologi
Broad Categories
Pharmacology
Cellular Membrane Transporters & Receptors
Drug Delivery Systems
Cancer Drugs
Protein Structure & Folding
Genetics & Genomics
Neurodegenerative Disorders
Substance Abuse
MeSH Descriptors
Pharmacology
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1016/j.pharmr.2026.100165
Open DOI
Melanotransferrin: Context-Dependent Biology, Pharmacological Targeting, and Therapeutic Delivery
02
03
DOI 10.1016/j.pharmr.2026.100163
Open DOI
Glycosylation in Quality and Safety of Therapeutic Proteins
04
DOI 10.1016/j.pharmr.2026.100162
Open DOI
Defining the Druggability of Viral Macrodomains in Coronaviruses and Alphaviruses
05
DOI 10.1016/j.pharmr.2026.100161
Open DOI
Medication adherence: An overlooked critical determinant of pharmacological effectiveness
06
DOI 10.1016/j.pharmr.2026.100160
Open DOI
The promise of biased ligands in therapeutics
07
DOI 10.1016/j.pharmr.2026.100159
Open DOI
GPCR signaling from a primary cilium perspective
08
09
DOI 10.1016/j.pharmr.2026.100157
Open DOI
Application of human liver cell models in drug development and toxicity studies: The role of membrane transporters
10
DOI 10.1016/j.pharmr.2026.100156
Open DOI
Regulation of the Mineralocorticoid Receptor in Physiology and Disease
Bibliographical & Catalog Notes
Vol. 2- issued under the sponsorship of the American Society for Pharmacology and Experimental Therapeutics, the British Pharmacological Society, and the Scandinavian Pharmacological Society (Nordisk Selskab for Farmakologi).
Place of publication varies.
Print issues ceased with v. 63, no. 4 (2011).
Vol. 1-2 issued as part 2 of Apr., Aug., and Dec. numbers of the Journal of pharmacology and experimental therapeutics, v. 95-100.
Available also online.
Microfilm. v. 1 (1949)-15 (1963). 5 microfilm reels : negative ; 35 mm.
Vol. 47, no. 1 (MAR 1995)19950518 Notice not published Printed on acid-free paper